Di Wu

Di Wu

Central US Merck & Co., Inc. - Kenilworth / United States
Others
AD Scientific Index ID: 5568596
-
person_outline Di Wu's MOST POPULAR ARTICLES
1-) Nanomedicine applications in the treatment of breast cancer: current state of the artD Wu, M Si, HY Xue, HL WongInternational journal of nanomedicine, 5879-5892, 20171762017
2-) Applications, challenges, and outlook for PBPK modeling and simulation: a regulatory, industrial and academic perspectiveW Lin, Y Chen, JD Unadkat, X Zhang, D Wu, T HeimbachPharmaceutical Research 39 (8), 1701-1731, 2022692022
3-) Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugsD Wu, M Sanghavi, S Kollipara, T Ahmed, AK Saini, T HeimbachPharmaceutical Research 40 (2), 337-357, 2023332023
4-) Current state and challenges of physiologically based biopharmaceutics modeling (PBBM) in oral drug product developmentD Wu, M LiPharmaceutical Research 40 (2), 321-336, 2023212023
5-) Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brainP Guo, M Si, D Wu, HY Xue, W Hu, HL WongJournal of Controlled Release 328, 696-709, 2020172020